BLOOD TRIGGERED RAPID RELEASE POROUS NANOCAPSULES

Area of Science:

• Materials Science
• Biomedical Engineering
• Nanotechnology

Background:

• Traditional drug delivery systems focus on slow release for steady drug concentration.
• Emergency care requires rapid drug administration, a need not met by current slow-release formulations.
• Development of rapid-release systems is crucial for time-sensitive medical interventions.

Purpose of the Study:

• To create a novel rapid-release drug delivery system for emergency medical treatments.
• To engineer hollow polyacrylate nanocapsules with porous walls for burst drug release.
• To investigate the mechanism of drug release triggered by blood components.

Main Methods:

• Fabrication of hollow polyacrylate nanocapsules with nanometer-thin porous walls.
• Encapsulation of indocyanine green (ICG) as a model drug cargo.
• In vitro testing using albumin solutions and serum to assess release kinetics.
• Scanning Electron Microscopy (SEM) and light scattering for structural analysis.
• In vivo studies using fluorescence lifetime imaging for pharmacokinetic evaluation.

Main Results:

• ICG-loaded nanocapsules exhibited a shelf life of twelve months with no premature drug release.
• Rapid release of ICG was observed in vitro upon interaction with albumin and serum.
• Nanocapsule architecture remained intact post-drug release, as confirmed by SEM and light scattering.
• In vivo studies demonstrated rapid discharge of ICG after intravenous administration.

Conclusions:

• The developed hollow polyacrylate nanocapsules are effective for rapid drug delivery in emergency care.
• Albumin-mediated conformational changes in the polymer shell likely trigger the burst release mechanism.
• These nanocapsules show promise for improving emergency treatment efficacy due to their rapid release profile and stability.